Yahoo España Búsqueda web

Search results

  1. 31 de may. de 2024 · School of the Museum of Fine Arts at Tufts University 230 The Fenway Boston, MA 02115. Admissions: 617-627-0077 Main Line: 617-627-0012 Directions. Directory

  2. Hace 16 horas · Catarina de San Juan. In 1688, a local hero passed away in the city of Puebla in Mexico. Her name was Catarina de San Juan. She was born not in Mexico but in South Asia as Mirra. Then one day, she was standing on a beach when Portuguese sailors captured her. They took her to Malabar in southern India where they baptized her as Catarina.

  3. Hace 54 segundos · En tanto, Randi Foraker, profesora de medicina en el Instituto de Informática, Ciencia de Datos y Bioestadística y directora del Centro de Informática de la Salud de la Población, de la ...

  4. Hace 4 horas · 60 Degrees Pharmaceuticals has entered an agreement with Tufts Medical Center to conduct a clinical trial that will evaluate the safety and efficacy of tafenoquine for the treatment of babesiosis in humans; The study will be the world’s first clinical trial to evaluate tafenoquine in human babesiosis patients Enrollment will begin after a site initiation visit in Boston on June 13, 2024

  5. Hace 16 horas · 60 Degrees Pharmaceuticals has entered an agreement with Tufts Medical Center to conduct a clinical trial that will evaluate the safety and efficacy of tafenoquine for the treatment of babesiosis ...

  6. Hace 4 horas · 60 Degrees Pharmaceuticals, Inc. announced it has entered into an agreement with Tufts Medical Center in Boston to conduct the world's first clinical trial evaluating the efficacy and safety of tafenoquine in treating human babesiosis patients.

  7. Hace 16 horas · The agreement with Tufts Medical Center marks a significant step for 60 Degrees Pharmaceuticals.Entering the clinical trial phase for tafenoquine in treating babesiosis could potentially diversify the company's revenue streams.If the trials are successful, it could lead to FDA approval for a new indication, thereby expanding the market for tafenoquine.